Trials / Unknown
UnknownNCT04674020
Registry for Migraine - Structural and Functional MRI Before and After Erenumab Treatment
Registry for Migraine - Structural and Functional Magnetic Resonance Imaging Before and After Erenumab Treatment
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Danish Headache Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate structural and functional cerebral changes using magnetic resonance imaging before and after treatment with erenumab in patients with migraine.
Detailed description
Migraine is a prevalent neurological disorder and a leading cause of years lived with disability worldwide. As of recent, therapies targeting calcitonin gene-related peptide (e.g. erenumab) have been approved for the preventive treatment of migraine. This study aims to investigate structural and functional cerebral changes using magnetic resonance imaging before and after treatment with erenumab in patients with migraine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Erenumab | Erenumab 70 mg or 140 mg packed in a SureClick® Autoinjector Pen (AI) |
Timeline
- Start date
- 2020-10-22
- Primary completion
- 2025-07-22
- Completion
- 2025-07-22
- First posted
- 2020-12-17
- Last updated
- 2022-01-10
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04674020. Inclusion in this directory is not an endorsement.